Clin2
NCT07450144Possibly a fitRecruiting

Chatbot to Help Reduce Alcohol in Fatty Liver Disease

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Alcohol-Related Liver Disease

Part of Digestive system, Hormones & metabolism, Mental health clinical trials.

This study tests a chatbot that helps people with fatty liver disease reduce how much they drink. If you drink regularly and are ready to change, this tool could support you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You live in Hong Kong and are 18 or older
  • You have been diagnosed with MASLD (a type of fatty liver disease related to your metabolism)
  • You currently drink a moderate-to-high amount of alcohol each week (about 3–5 standard drinks a day for men, or 2–4 for women)
  • You are ready to cut back or stop drinking
  • You can read and speak Chinese
  • You own a smartphone with internet access

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06920316Not yet recruiting· Phase 4
Digital diet and exercise for liver scarring in fatty liver disease

This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.

London, London
NCT07381868Recruiting
Social media support group for women who drink

This study tests whether a private social media support group can help women cut back on risky drinking. It's for women who drink more than they'd like and want to try a supportive online group.

Hong Kong
NCT07214831Not yet recruiting
Chatbot for reducing risky drinking in young adults

This study tests a chatbot designed to help young adults ages 18-29 who drink at risky levels cut back on alcohol. The chatbot offers brief advice and support through conversations.

Boston, Massachusetts
NCT06305624Recruiting
Smartphone app to help people with alcohol-related liver disease stop drinking

This trial tests whether a smartphone program can help people with alcohol-related liver disease reduce or stop drinking. If you have liver disease related to alcohol and have used alcohol in the past 6 months, this app-based support may be for you.

Lansing, Michigan
NCT07032311Not yet recruiting
Digital therapy to lower diabetes and fatty liver risk

This trial tests a smartphone app that sends you text messages and coaching to help you eat better, be more active, and control your blood sugar. It is for people with diabetes or prediabetes who also have signs of fatty liver disease.

Jamaica, New York
NCT07637539Not yet recruiting
Brief Counseling for Alcohol and Liver Health During Hospital Stay

This study tests whether a brief conversation with a counselor during your hospital stay can help reduce drinking and protect your liver. You'll receive an ultrasound-like scan to measure liver stiffness and personalized advice about cutting back on alcohol.

Bergen

Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.